Research Use Only - Not for human consumption. 18+ only.

Epithalon vs NAD+

Evidence-based comparison · Updated 2026

Summary

Epithalon and NAD+ both target aging but through distinct mechanisms. Epithalon is best suited for research focused on telomere biology and pineal-driven circadian regulation, while NAD+ is more broadly studied for mitochondrial energy metabolism, DNA repair, and sirtuin activation. Researchers prioritizing cellular energetics and metabolic function tend toward NAD+; those focused on telomere length and circadian aging lean toward Epithalon.

Side-by-Side Comparison

EpithalonNAD+
EvidenceBGrade BSmaller human trials, observational studies, or approved in 30+ countries
RegulatoryResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Benefits
  • +Telomerase activation (may lengthen telomeres)
  • +Anti-aging properties
  • +Regulates melatonin production
  • +May increase lifespan
  • +Improves sleep quality
  • +Supports cellular energy production and ATP synthesis
  • +Enhances mitochondrial function and oxidative metabolism
  • +Promotes NAD+-dependent DNA repair mechanisms
  • +May improve exercise endurance and recovery
  • +Supports metabolic flexibility and fat oxidation
Dosage5-10 mg mg — Daily for 10-20 days250-500 mcg — 1-2x daily
RouteSubcutaneous, IntramuscularSubcutaneous
CategorySkin & Anti-AgingMetabolic & Weight Loss

Which Should You Choose?

Epithalon operates primarily at the level of telomerase activation and pineal gland modulation, while NAD+ functions as a universal redox coenzyme powering mitochondrial metabolism, DNA repair enzymes, and sirtuin-dependent longevity pathways. These two compounds address aging through largely non-overlapping biological targets.

Choose Epithalon when:

  • +Research focus is on telomere attrition and cellular replicative aging, where Epithalon's proposed telomerase activation mechanism is directly relevant.
  • +Study involves circadian rhythm disruption or melatonin dysregulation, as Epithalon is derived from a pineal gland extract and has been studied for these effects.
  • +Interest is in neuroprotective or lifespan-extending mechanisms that are independent of energy substrate availability.

Choose NAD+ when:

  • +Research focus centers on mitochondrial dysfunction, metabolic decline, or age-related drops in cellular ATP production, where NAD+ serves as a direct substrate.
  • +Study involves DNA damage repair pathways or PARP-dependent genomic stability, both of which depend on NAD+ availability.
  • +Interest is in sirtuin activation, metabolic flexibility, or exercise recovery, where NAD+ precursor restoration has a more established research base.

Stacking Epithalon with NAD+ precursors is conceptually plausible in longevity research given their complementary and non-redundant mechanisms, though no published studies have formally evaluated this combination.

Frequently Asked Questions

Do Epithalon and NAD+ work on the same aging pathways, or are they targeting different mechanisms?
These two compounds target largely distinct aging mechanisms. Epithalon is theorized to act on telomerase activity and telomere maintenance, which relates to replicative cellular aging and pineal function. NAD+ addresses metabolic aging by fueling sirtuins, PARPs, and mitochondrial oxidative phosphorylation. There is minimal mechanistic overlap, which is why researchers sometimes consider combining them rather than choosing one exclusively.
Which has a stronger evidence base: Epithalon or NAD+?
Epithalon carries a grade B evidence rating based on animal and limited human studies, particularly from Russian research programs examining telomere effects and lifespan extension. NAD+ research is extensive in preclinical models but its evidence grade in this context is listed as unknown, reflecting variability in human clinical outcomes and ongoing debate about optimal delivery methods. Neither compound has robust, large-scale human clinical trial data supporting anti-aging claims.
Would stacking Epithalon with NAD+ or its precursors offer additive benefits in longevity research?
From a mechanistic standpoint, combining Epithalon with NAD+ precursors such as NMN or NR could be rationally justified, as they act on separate hallmarks of aging: telomere shortening versus metabolic and genomic decline. However, no published research has examined this stack directly, so any additive or synergistic effect remains speculative. Researchers designing protocols involving both should account for this absence of combination data.
How do the research timelines and expected effect windows differ between Epithalon and NAD+?
NAD+ supplementation or infusion has been associated with relatively rapid shifts in cellular energy markers, with some studies noting metabolic changes within days to weeks of intervention. Epithalon's proposed effects on telomere length and circadian regulation are considered slower and more cumulative, typically studied over weeks to months in animal models. This difference in effect timeline means they may not be directly comparable within the same short-duration research window.

Goal-Based Guides

Broader evidence guides for the goals this comparison relates to.

Not sure which fits your research goals?

Use the Goal Finder

Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.

Find My Peptide →